Abstract
Gallbladder and bile duct carcinomas belong to the family of biliary tract tumors, but they demonstrate different clinical behavior. We evaluated a series of biliary tract carcinomas to determine whether they also had genotypic differences by analysis of the tumor suppressor genes DPC4 and p53. Twenty-one gallbladder cancers, 20 intrahepatic bile duct carcinomas, and 10 extrahepatic bile duct carcinomas were retrieved from the surgical pathology files of Kaohsiung Medical University Hospital. Sections were immunostained with monoclonal antibodies to the DPC4 and P53 proteins. Statistical differences between gallbladder cancer and bile duct carcinomas were determined using ?2 analysis or the Fisher’s exact test, when appropriate. Two of the 21 gallbladder cancers (9.5%), 7 of the 20 intrahepatic bile duct carcinomas (35%), and five of the 10 extrahepatic bile duct carcinomas (50%) were negatively labeled for DPC4. The differences were significant between gallbladder carcinoma and both intrahepatic bile duct carcinomas (p = 0.023) and extrahepatic bile duct carcinomas (p = 0.012). A higher frequency of P53 overexpression was found in gallbladder cancers (61.9%) than in intrahepatic bile duct carcinomas (26.3%) (p = 0.024). This study suggests that the DPC4 gene may play a limited role in gallbladder carcinoma; however, p53 gene mutation is more frequently found in gallbladder cancers. In contrast, DPC4 deletion may be more common in bile duct carcinomas, especially in those arising from the extrahepatic bile duct. These findings support the concept that gallbladder and bile duct carcinomas are different tumors with differing etiologies and tumorigenesis.
Similar content being viewed by others
References
B Adanja Z Gledovic T Pekmezovic et al. (2000) ArticleTitleMortality trends of malignant tumours of digestive organs in Belgrade, Yugoslavia, 1975-1997 Dig. Liver Dis. 32 386–391 Occurrence Handle10.1016/S1590-8658(00)80258-3 Occurrence Handle1:STN:280:DC%2BD3cvnvVCnsQ%3D%3D Occurrence Handle11030183
EC Lazcano-Ponce JF Miquel N Munoz et al. (2001) ArticleTitleEpidemiology and molecular pathology of gallbladder cancer CA Cancer J. Clin. 51 349–364 Occurrence Handle1:STN:280:DC%2BD38%2FjsVOjtw%3D%3D Occurrence Handle11760569
C Urbani K Palmer (2001) ArticleTitleDrug-based helminth control in Western Pacific countries: a general perspective Trop. Med. Int. Health 6 935–944 Occurrence Handle10.1046/j.1365-3156.2001.00820.x Occurrence Handle1:STN:280:DC%2BD3MnltFyjsA%3D%3D Occurrence Handle11703849
PC Groen Particlede GJ Gores NF LaRusso et al. (1999) ArticleTitleBiliary tract cancers N. Engl. J. Med. 341 1368–1378
I Baxter OJ Garden (1999) ArticleTitleSurgical palliation of carcinoma of the gallbladder Hepatogastroenterology 46 1572–1577 Occurrence Handle1:STN:280:DyaK1MzlsleltA%3D%3D Occurrence Handle10430297
C Sergi S Adam P Kahl et al. (2000) ArticleTitleThe remodeling of the primitive human biliary system Early Hum. Dev. 58 167–178 Occurrence Handle10.1016/S0378-3782(00)00065-7 Occurrence Handle1:STN:280:DC%2BD3cvot1CgtQ%3D%3D Occurrence Handle10936437
P Eyken ParticleVan R Sciot F Callea et al. (1988) ArticleTitleThe development of the intrahepatic bile ducts in man: a keratin-immunohistochemical study Hepatology 8 1586–1595 Occurrence Handle2461337
V Vijayan CE Tan (1997) ArticleTitleDeveloping human biliary system in three dimensions Anat. Rec. 249 389–398 Occurrence Handle10.1002/(SICI)1097-0185(199711)249:3<389::AID-AR10>3.0.CO;2-K Occurrence Handle1:STN:280:DyaK1c%2FjvFCnsA%3D%3D Occurrence Handle9372173
SA Hahn M Schutte AT Hoque et al. (1996) ArticleTitleDPC4, a candidate tumor suppressor gene at human chromosome 18q21.1 Science 271 350–353 Occurrence Handle1:CAS:528:DyaK28XlsFartg%3D%3D Occurrence Handle8553070
Y Zhang X Feng R We et al. (1996) ArticleTitleReceptor-associated Mad homologues synergize as effectors of the TGF-beta response Nature 383 168–172 Occurrence Handle10.1038/383168a0 Occurrence Handle1:CAS:528:DyaK28Xls12rt7o%3D Occurrence Handle8774881
E Montgomery M Goggins S Zhou et al. (2001) ArticleTitleNuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects Am. J. Pathol. 158 537–542 Occurrence Handle1:CAS:528:DC%2BD3MXhsFWmt7s%3D Occurrence Handle11159190
G Lagna A Hata A Hemmati-Brivanlou et al. (1996) ArticleTitlePartnership between DPC4 and SMAD proteins in TGF-beta signalling pathways Nature 383 832–836 Occurrence Handle10.1038/383832a0 Occurrence Handle1:CAS:528:DyaK28Xms1Sisrg%3D Occurrence Handle8893010
JL Dai KK Turnacioglu M Schutte et al. (1998) ArticleTitleDpc4 transcriptional activation and dysfunction in cancer cells Cancer Res. 58 4592–4597 Occurrence Handle1:STN:280:DyaK1M%2Fgt1KmtQ%3D%3D Occurrence Handle9788608
P Argani A Shaukat M Kaushal et al. (2001) ArticleTitleDiffering rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts Cancer 91 1332–1341
K Shiraishi N Kusano S Okita et al. (1999) ArticleTitleGenetic aberrations detected by comparative genomic hybridization in biliary tract cancers Oncology 57 42–49 Occurrence Handle10.1159/000011999 Occurrence Handle1:CAS:528:DyaK1MXksFaksb4%3D Occurrence Handle10394124
SA Hahn D Bartsch A Schroers et al. (1998) ArticleTitleMutations of the DPC4/Smad4 gene in biliary tract carcinoma Cancer Res. 58 1124–1126 Occurrence Handle1:CAS:528:DyaK1cXhvV2ku7c%3D Occurrence Handle9515793
MT Barrett M Schutte SE Kern et al. (1996) ArticleTitleAllelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma Cancer Res. 56 4351–4353 Occurrence Handle1:CAS:528:DyaK28XmtVyltrk%3D Occurrence Handle8813122
M Nagatake Y Takagi H Osada et al. (1996) ArticleTitleSomatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers Cancer Res. 56 2718–2720 Occurrence Handle1:CAS:528:DyaK28XjsFGku7w%3D Occurrence Handle8665501
MJ Calonge J Massague (1999) ArticleTitleSmad4/DPC4 silencing and hyperactive Ras jointly disrupt transforming growth factor-beta antiproliferative responses in colon cancer cells J. Biol. Chem. 274 33637–33643 Occurrence Handle10.1074/jbc.274.47.33637 Occurrence Handle1:CAS:528:DyaK1MXns1ejsLY%3D Occurrence Handle10559252
I Schwarte-Waldhoff S Klein S Blass-Kampmann et al. (1999) ArticleTitleDPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression Oncogene 18 3152–3158 Occurrence Handle10.1038/sj.onc.1202641 Occurrence Handle1:CAS:528:DyaK1MXjs1OnurY%3D Occurrence Handle10340387
JP Winter Particlede BA Roelen P Dijke Particleten et al. (1997) ArticleTitleDPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells Oncogene 14 1891–1899 Occurrence Handle10.1038/sj.onc.1201017 Occurrence Handle9150356
D Wang T Kanuma H Mizunuma et al. (2000) ArticleTitleAnalysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer Cancer Res. 60 4507–4512 Occurrence Handle1:CAS:528:DC%2BD3cXmsVahsrk%3D Occurrence Handle10969799
Y Zhou H Kato D Shan et al. (1999) ArticleTitleInvolvement of mutations in the DPC4 promoter in endometrial carcinoma development Mol. Carcinog. 25 64–72 Occurrence Handle10.1002/(SICI)1098-2744(199905)25:1<64::AID-MC8>3.0.CO;2-Z Occurrence Handle1:CAS:528:DyaK1MXjtFSku7Y%3D Occurrence Handle10331746
HJ Chang SW Kim YT Kim et al. (1999) ArticleTitleLoss of heterozygosity in dysplasia and carcinoma of the gallbladder Mod. Pathol. 12 763–769 Occurrence Handle1:STN:280:DyaK1MzptFWiug%3D%3D Occurrence Handle10463477
JV Gannon R Greaves R Iggo et al. (1990) ArticleTitleActivating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form EMBO J. 9 1595–1602 Occurrence Handle1:CAS:528:DyaK3cXktFyrsrk%3D Occurrence Handle1691710
K Washington MR Gottfried (1996) ArticleTitleExpression of p53 in adenocarcinoma of the gallbladder and bile ducts Liver 16 99–104 Occurrence Handle1:STN:280:BymA3czjs1M%3D Occurrence Handle8740842
K Fujii H Yokozaki W Yasui et al. (1996) ArticleTitleHigh frequency of p53 gene mutation in adenocarcinomas of the gallbladder Cancer Epidemiol. Biomarkers Prev. 5 461–466 Occurrence Handle1:CAS:528:DyaK28Xkt1Kqtbs%3D Occurrence Handle8781743
A Nakeeb PA Lipsett KD Lillemoe et al. (1996) ArticleTitleBiliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma Am. J. Surg. 171 147–152 Occurrence Handle10.1016/S0002-9610(99)80090-7 Occurrence Handle1:STN:280:BymC2c3htVc%3D Occurrence Handle8554130
DJ Flavell (1981) ArticleTitleLiver-fluke infection as an aetiological factor in bile-duct carcinoma of man Trans. R. Soc. Trop. Med. Hyg. 75 814–824 Occurrence Handle10.1016/0035-9203(81)90419-3 Occurrence Handle1:STN:280:Bi2C3s%2FhtlE%3D Occurrence Handle6277052
S Kubo H Kinoshita K Hirohashi et al. (1995) ArticleTitleHepatolithiasis associated with cholangiocarcinoma World J. Surg. 19 637–641 Occurrence Handle1:STN:280:ByqH3cjhvVc%3D Occurrence Handle7676713
YT Kim JS Byun J Kim et al. (2003) ArticleTitleFactors predicting concurrent cholangiocarcinomas associated with hepatolithiasis Hepatogastroenterology 50 8–12 Occurrence Handle12629979
KM Boberg A Bergquist S Mitchell et al. (2002) ArticleTitleCholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation Scand. J. Gastroenterol. 37 1205–1211 Occurrence Handle10.1080/003655202760373434 Occurrence Handle1:STN:280:DC%2BD38nkvVyltw%3D%3D Occurrence Handle12408527
N Chalasani A Baluyut A Ismail et al. (2000) ArticleTitleCholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study Hepatology 31 7–11 Occurrence Handle10.1002/hep.510310103 Occurrence Handle1:STN:280:DC%2BD3c%2FotVynsQ%3D%3D Occurrence Handle10613720
DM Parkin H Ohshima P Srivatanakul et al. (1993) ArticleTitleCholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention Cancer Epidemiol. Biomarkers Prev. 2 537–544 Occurrence Handle1:STN:280:ByuD1Mzjs1Q%3D Occurrence Handle8268770
M Lesurtel JM Regimbeau O Farges et al. (2002) ArticleTitleIntrahepatic cholangiocarcinoma and hepatolithiasis: an unusual association in Western countries Eur. J. Gastroenterol. Hepatol. 14 1025–1027
T Patel (2001) ArticleTitleIncreasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States Hepatology 33 1353–1357 Occurrence Handle10.1053/jhep.2001.25087 Occurrence Handle1:STN:280:DC%2BD3MzhvFajsw%3D%3D Occurrence Handle11391522
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chuang, SC., Lee, KT., Tsai, KB. et al. Immunohistochemical Study of DPC4 and p53 Proteins in Gallbladder and Bile Duct Cancers. World J. Surg. 28, 995–1000 (2004). https://doi.org/10.1007/s00268-004-7447-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-004-7447-8